Ooops... Something went wrong while loading this page.

Company announcement - No. 11 / 2025 Zealand Pharma Announces Financial Results for the First Three Months of 2025 Significant progress in the clinical pipeline, strengthening of organizational capabi ...

Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the ...

SYDNEY--(BUSINESS WIRE)--#clinicaltrials--Novotech, a leading global clinical research organization (CRO ... Strongly linked to conditions such as type 2 diabetes, cardiovascular disease, ...

Benefits of a Keto Diet for People With Diabetes Research has found that the keto diet can provide ... Most strips come with a color chart that you will use to compare your strip to. Speak with your ...

AUSTIN, Texas, May 7, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...

Biomea Fusion is following through on a New Year’s resolution to become a metabolic-focused company. | Biomea Fusion is ...

The role of EGFR in KRASG12D-driven tumorigenesis was studied using mouse CRC organoids with KRAS-APC-TP53 mutations and ...

Awards Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES, May 08, 2025 (GLOBE ...

REYKJAVIK, Iceland, May 08, 2025 (GLOBE NEWSWIRE) -- Lucinity has been listed among the top 50 Financial Crime and Compliance (FCC) companies in the 2025 FCC50 ranking by Chartis Research.

According to new research out of the Cornell SC Johnson College of Business, political affiliation could be one indicator of negotiation propensity. Analyzing data involving more than 56,000 ...

A panel at OCT Europe touched upon where the European clinical trial industry is headed and the impact of technology and ...